DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Morgan Stanley - 1 Goldman Sachs - 1 Goldman - 1 it's - 1 BIRK - 1 ramping - 1 Stifel - 1 Wells - 1
Top related locs:
China Taiwan Asia TFX McDonald's Rivian
Top related orgs:
UBS - 1 Apple - 1 Verizon - 1 AT - 1 Gannett - 1 JMP - 1 Sports - 1 JPMorgan - 1

Search resuls for: "TFX"


2 mentions found


☆ Here are Monday's biggest analyst calls: Tesla, Nvidia, Verizon, Apple, McDonald's, Birkenstock, AT&T, Meta & more
  + stars: | 2024-07-01 | by ( Michael Bloom | ) www.cnbc.com   time to read: +5 min
Morgan Stanley reiterates Nvidia as overweight Morgan Stanley raised its price target on the stock to $144 per share from $116. "We are initiating coverage of Gauzy with a Buy rating and $18 12-month price target." Wells Fargo reiterates McDonald's as overweight Wells said it's standing by its overweight rating on shares of McDonald's. "We initiate coverage on Amkor Technology (AMKR, $10B market cap) with an Overweight rating and Dec-25 price target of $48." Raymond James reiterates Meta as strong buy Raymond James raised its price target on Meta to $600 per share from $550.
Persons: Morgan Stanley, Goldman Sachs, Goldman, it's, BIRK, ramping, Stifel, Wells, Tesla, JMP, Academy's, Piper Sandler, Piper, TD Cowen, W.R, Berkley, Snowflake, Raymond James, Rivian, Meta Organizations: UBS, Apple, Verizon, AT, Gannett, JMP, Sports, JPMorgan, Amkor Technology, Deutsche Bank, Walmart, Deutsche, Exchange, ICE, RBC, NextEra Energy Partners, Fox Corp, EV, Meta Locations: China, Taiwan, Asia, TFX, McDonald's, Rivian
☆ U.S. FDA classifies recall of Teleflex's respiratory filters as most serious
  + stars: | 2022-11-01 | by ( ) www.reuters.com   time to read: +1 min
Nov 1 (Reuters) - U.S. health regulators on Tuesday classified the recall of Teleflex Inc's (TFX.N) Iso-Gard filter S, a medical device to protect patients from potential airborne contaminants, as most serious, saying its use could lead to injuries or death. It had recalled about 2.7 million filters distributed between Sept. 1, 2020 to July 5, 2022. The company did not immediately respond to Reuters request for comment on the impact from the recall. There have been 36 complaints and 4 injuries, no reports of deaths or long-term injuries associated with the use of the product, the U.S. Food and Drug Administration (FDA) said on Tuesday. Reporting by Khushi Mandowara; Editing by Shinjini GanguliOur Standards: The Thomson Reuters Trust Principles.
0 next >>
Total: 2